Earlier this year, the American Academy of Pediatrics recognized Dr. Schmidt with the William A. Silverman Lectureship Award. The award recognizes an individual whose work has significantly advanced neonatal ethics or the field of neonatal evidence-based medicine.
Researchers from the Children's Oncology Group (COG) have developed a new standardized dosing method for anticancer drugs in infants to use across all COG clinical trials. This unified method, based on dose banding and organized into tables for different drugs and dose levels, will address the limitations and variability that researchers can encounter in current methods.
More mothers are breastfeeding than ever before. However, getting breastfeeding going can be difficult. Babies with inherited metabolic disorders, such as medium-chain acyl-CoA dehydrogenase deficiency (let's just call it MCAD) can be especially vulnerable to low blood sugar if they aren't getting enough milk in the early days of breastfeeding.
Caffeine therapy can help premature babies breathe stronger and sooner on their own. When a group of caffeine-treated premature babies reached middle school, the therapy appeared to reduce their risk of motor impairment – building on earlier follow-ups that show the treatment's safety, efficacy, and developmental benefits for the babies at one-and-a-half years old.
Every week is full of discovery at The Children’s Hospital of Philadelphia. Among the highlights this week are a significant discovery and new treatment option in a heart surgery complication that affects young patients; a study of how to predict infants’ later obesity risk; and a CHOP cancer immunotherapy story hitting the world stage at an international conference.
